Cell proliferation control using
yeast as model eukaryotes
Over the last 10 years, we have focussed on the study of yeast cell
proliferation, particularly in response to zymocin which is a trimeric
(abg) toxin complex from Kluyveromyces lactis that kills
Saccharomyces cerevisiae.
The overall goal of our research into this
yeast pathosystem has been to use the power of budding yeasts as
eukaryotic models to provide insights into organismic interaction and
microbial competition. Using molecular techniques, we have genetically
dissected the lethal response towards zymocin, which results in a G1
cell cycle arrest, into a multi-step pathway that involves ~30 genes.
It initiates with docking of zymocin onto cell wall chitin and
chitinolysis by zymocin's a-subunit. Subsequently, early events that
mediate import and activation of zymocin's lethal g-toxin subunit
require plasma membrane sphingolipid synthesis and the proton pump
Pma1. Intracellularly, g-toxicity requires the Elongator complex
(Elp1-6),
Elongator-related proteins (Kti11-14: k iller t oxin i nsensitive) and
tRNA methylase Trm9. These zymocin players were isolated in our group
using genome-wide transposon mutagenesis to identify toxin resistant S.
cerevisiae mutants or single-copy complementation of existing kti
mutants generated in the group of Stark at Dundee. As shown by the
Svejstrup group, Elongator is a histone acetylase (HAT) that partners
with RNA polymerase II. By virtue of its HAT activity, Elongator is
thought to assist transcription by RNA polymerase II through chromatin.
In further support of a transcriptional role, Elongator binds unspliced
nascent mRNAs that emanate from the transcription machinery in the
nucleus. |
| *
|
Elongator function in
zymocin-dependent growth inhibition
Apart from this, Elongator is related to processes as diverse as
tubulin and tRNA modification. Whether these depend on Elongator's
transcriptional functions is not known. Strikingly, however, the group
of Byström has shown that Elongator's role in tRNA
modification is required for the generation of modified uridines (U34)
at the wobble position of tRNA anticodons including
5-methoxycarbonyl-methyl-2-thiouridine (mcm5s2U34). Although it is
unclear how Elongator takes part in U34 modification , it is required
for suppression of non-/missense mutations by U34-carrying tRNA
suppressors. So Elongator may influence anticodon/codon interaction,
tRNA decoding and thereby mRNA translation. In further support of a
link between Elongator and tRNA functioning, zymocin's g-toxin is a
tRNase that cleaves tRNA anticodons that carry mcm5s2U34 . Since the
full modification depends on Elongator and tRNA methylase Trm9, this
provides an explanation why Elongator and trm9 mutants survive zymocin:
they efficiently protect against the tRNase attack of g -toxin. Our
recent data that expression of ELO2, the Arabidopsis homolog of the
yeast Elongator subunit Elp1, reconfers zymocin sensitivity to a yeast
elp1 mutant, imply that Elongator roles in tRNA modification may have
been conserved among eukaryotes. Moreover, we have provided preliminary
evidence that Elongator function is subject to phosphomodulation of
Elp1. |
| *
|
Kti11 – a versatile
partner of protein complexes with roles in cell proliferation
Intriguingly, Elongator partner protein Kti11 not only mediates cell
death by zymocin but is also known as Dph3. Dph3 is one of five
components that are required for diphthamide synthesis on translational
elongation factor EF2. Although the physiological role of diphthamide
is unknown, this exotic protein modification serves as the target for
lethal ADP-ribosylation of EF2 by bacterial toxins including diphtheria
toxin and exotoxin A. So, Kti11/Dph3 appears to be a versatile partner
of proteins involved in cell proliferation and growth. Not
surprisingly, the mammalian homolog of DPH1, encoding a partner of
Kti11/Dph3, is known as a tumour suppressor gene in ovarian cancer
(OVCA1) formation. |